Skip to main content

Biotech Startups, VCs Seek Path Forward After A Bruising Year

Mintz Member Joshua Fox spoke to the Wall Street Journal about what's ahead for biotech startups and venture capitalists following a difficult year. Joshua said, "Entrepreneurs seeking to start biotechs worry they won’t be able to attract sufficient capital, while some of those seeking new venture rounds fear they will be unable to raise enough to reach the next significant milestone before their cash runs out. Time is of the essence."


The Wall Street Journal